Quell Therapeutics - Opportunities and Challenges in Biotech, 2024
Quell Therapeutics is a London, UK based, private biopharmaceutical company. Their vision is to be the leading engineered cell therapy company, bringing transformational and valued therapies addressing a range of autoimmune and inflammatory diseases, as well as preventing rejection in organ transplantation.
Date: 18 January 2024, 12:00 (Thursday, 1st week, Hilary 2024)
Venue: IMS-Tetsuya Nakamura Building, Roosevelt Dr, Headington OX3 7TY
Venue Details: Ground Floor Seminar Room - followed by lunch and networking. Also available via Zoom.
Speaker: Luke Devey (Vice President, Head of Translational Science, Immunology)
Organising department: Medical Sciences Office
Organisers: Sheena Lee (MSD Business Partnerships Office), Dr Charlotte Bell (University of Oxford), Medical Sciences Division Business Partnerships Office (University of Oxford)
Organiser contact email address: sheena.lee@medsci.ox.ac.uk
Hosts: Sheena Lee (MSD Business Partnerships Office), Dr Charlotte Bell (University of Oxford)
Part of: Industry Insight Seminar Series
Booking required?: Required
Booking url: https://forms.office.com/e/suZ1J5CiU1
Cost: Free
Audience: Public
Editor: Sheena Lee